Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Heron Therapeutics (HRTX) Interest Expenses (2016)

Historic Interest Expenses for Heron Therapeutics (HRTX) over the last 3 years, with Q4 2016 value amounting to $2.0 million.

  • Heron Therapeutics' Interest Expenses changed N/A to $2.0 million in Q4 2016 from the same period last year, while for Sep 2017 it was $2.0 million, marking a year-over-year increase of 88086.12%. This contributed to the annual value of $6.0 million for FY2024, which is 5594.62% up from last year.
  • As of Q4 2016, Heron Therapeutics' Interest Expenses stood at $2.0 million.
  • In the past 5 years, Heron Therapeutics' Interest Expenses registered a high of $2.0 million during Q4 2016, and its lowest value of $201000.0 during Q1 2013.
  • Over the past 3 years, Heron Therapeutics' median Interest Expenses value was $205000.0 (recorded in 2013), while the average stood at $573400.0.
  • Within the past 5 years, the most significant YoY rise in Heron Therapeutics' Interest Expenses was 49.5% (2013), while the steepest drop was 49.5% (2013).
  • Heron Therapeutics' Interest Expenses (Quarter) stood at $202000.0 in 2012, then rose by 3.47% to $209000.0 in 2013, then skyrocketed by 880.86% to $2.0 million in 2016.
  • Its last three reported values are $2.0 million in Q4 2016, $209000.0 for Q3 2013, and $205000.0 during Q2 2013.